Tenaya Therapeutics Stock Price To Earnings To Growth
Tenaya Therapeutics fundamentals help investors to digest information that contributes to Tenaya Therapeutics' financial success or failures. It also enables traders to predict the movement of Tenaya Stock. The fundamental analysis module provides a way to measure Tenaya Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Tenaya Therapeutics stock.
Tenaya |
Tenaya Therapeutics Company Price To Earnings To Growth Analysis
Tenaya Therapeutics' PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
CompetitionBased on the latest financial disclosure, Tenaya Therapeutics has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The price to earnings to growth for all United States stocks is 100.0% higher than that of the company.
Tenaya Price To Earnings To Growth Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tenaya Therapeutics' direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Tenaya Therapeutics could also be used in its relative valuation, which is a method of valuing Tenaya Therapeutics by comparing valuation metrics of similar companies.Tenaya Therapeutics is currently under evaluation in price to earnings to growth category among its peers.
Tenaya Fundamentals
| Return On Equity | -0.84 | ||||
| Return On Asset | -0.46 | ||||
| Current Valuation | 195.7 M | ||||
| Shares Outstanding | 79.22 M | ||||
| Shares Owned By Insiders | 1.17 % | ||||
| Shares Owned By Institutions | 73.73 % | ||||
| Number Of Shares Shorted | 13.12 M | ||||
| Price To Book | 2.31 X | ||||
| EBITDA | (122.51 M) | ||||
| Net Income | (124.08 M) | ||||
| Cash And Equivalents | 180.92 M | ||||
| Cash Per Share | 4.37 X | ||||
| Total Debt | 12.42 M | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 9.91 X | ||||
| Book Value Per Share | 1.42 X | ||||
| Cash Flow From Operations | (102.07 M) | ||||
| Short Ratio | 3.29 X | ||||
| Earnings Per Share | (1.44) X | ||||
| Target Price | 18.75 | ||||
| Number Of Employees | 140 | ||||
| Beta | 2.35 | ||||
| Market Capitalization | 260.64 M | ||||
| Total Asset | 170.51 M | ||||
| Retained Earnings | (403.28 M) | ||||
| Working Capital | 88.85 M | ||||
| Net Asset | 170.51 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Tenaya Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tenaya Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tenaya Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tenaya Therapeutics Stock:Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tenaya Therapeutics. If investors know Tenaya will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tenaya Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Tenaya Therapeutics is measured differently than its book value, which is the value of Tenaya that is recorded on the company's balance sheet. Investors also form their own opinion of Tenaya Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Tenaya Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tenaya Therapeutics' market value can be influenced by many factors that don't directly affect Tenaya Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tenaya Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Tenaya Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tenaya Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.